Paradoxical real-life underuse of GLP-1 receptor agonists in type 2 diabetes patients with atherosclerotic cardiovascular disease: Underuse of GLP-1RAs in patients with ASCVD

Autor: Scheen, André J.
Zdroj: In Diabetes Epidemiology and Management April-June 2024 14
Databáze: ScienceDirect